4,965.00
+65.00
(1.33%)
Delayed:
11:47AM GMT+9
KOSDAQ
data delayed by 20 mins -
Disclaimer
Currency in KRW
| Range | 4,900.00 - 4,965.00 |
| 52 week | 2,700.00 - 5,360.00 |
| Open | 4,920.00 |
| Vol / Avg. | 13,534.00/89,135.00 |
| Mkt cap | 74.48B |
| P/E | 30.67 |
| Div/yield | 500.00/12.08 |
| EPS | 161.90 |
| Shares | 15.00M |
| Beta | - |
| Inst. own | - |
Key stats and ratios
| Q4 (Dec '12) | 2012 | |
| Net profit margin | -1.02% | 4.48% |
| Operating margin | 1.19% | 4.41% |
| EBITD margin | - | 11.93% |
| Return on average assets | -0.92% | 3.32% |
| Return on average equity | -1.21% | 3.95% |
| Employees | 64 | - |
| Carbon Disclosure Rating | - | - |
Address
230-7, Hwachi-Dong
YEOSU, 555280
South Korea
+82-61-6884600 (Phone)
+82-2-3648350 (Fax)
YEOSU, 555280
South Korea
+82-61-6884600 (Phone)
+82-2-3648350 (Fax)
Website links
External links
Advertisement
Description
KPX LIFESCIENCE.CO., LTD. is a Korea-based company engaged in the manufacture of pharmaceutical ingredients and pharmaceutical intermediates. The Company�s products include AMZ and CCIM, which are used as crop protection materials; EDP-CL, which is a antibiotic used as ingredient of piperacillin; PM06, which is used for treatment of allergic diseases, and DSIC, which is used as pharmaceutical intermediate. The Company also provides antibiotics and others. The Company distributes its products within domestic market and to overseas markets including Japan, the United States, Europe and others.
Officers and directors
| Jun Yeong Yang | Chief Executive Officer, Director | |
| Su Dong Choi | Assistant Managing Director, Director | |
| Je Ho Jeon | Internal Auditor | |
| Gi Byeong Chae | Director | |
| Sang Bong Oh | Director | |
| Gyu Mo Yang | Director | |
| Hui Tae Ahn | Non-Executive Independent Director |